We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Review · September 03, 2020

The Prevalence and Diagnostic Work-Up of PIK3CA Mutations in HR+/HER2– MBC

International journal of breast cancer


Additional Info

Disclosure statements are available on the authors' profiles:

International journal of breast cancer
A Systematic Review of the Prevalence and Diagnostic Workup of PIK3CA Mutations in HR+/HER2- Metastatic Breast Cancer
Int J Breast Cancer 2020 Aug 01;2020(xx)3759179, EJ Anderson, LE Mollon, JL Dean, TL Warholak, A Aizer, EA Platt, DH Tang, LE Davis

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading